A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...
C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Meet us in Dubai, Booth No. Z3 C19.
Dear customers,
Greetings from Era Biology.
We are pleased to invite you to the Medlab Middle East exhibition in Dubai.
The exhibition will take place on 6-9 Fe...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...